知搜-全球专利检索

  1. 登录
  2. 注册

搜索结果

4 条记录 (耗时 0.024 秒)

    38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
    1.
    发明申请
    38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof 审中-公开
    38650,28472,5495,65507,81588和14354人蛋白质的方法和组合物及其用途

    公开(公告)号：US20030009017A1

    公开(公告)日：2003-01-09

    申请号：US10012140

    申请日：2001-11-08

    发明人： Kevin R. Leiby ,  Rosana Kapeller-Libermann ,  Maria A. Glucksmann

    IPC分类号： C07H021/02 ,  C07H021/04

    CPC分类号： C12N9/6489 ,  C07K14/705 ,  C07K2319/00 ,  C12N9/78 ,  C12Y304/24057 ,  C12Y305/04004

    摘要： The invention provides isolated nucleic acids molecules, designated 38650, 28472, 5495, 65507, 81588 or 14354 nucleic acid molecules, which encode novel adenosine deaminase, glycoprotease, or seven transmembrane receptor family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 38650, 28472, 5495, 65507, 81588 or 14354 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 38650, 28472, 5495, 65507, 81588 or 14354 gene has been introduced or disrupted. The invention still further provides isolated 38650, 28472, 5495, 65507, 81588 or 14354 proteins, fusion proteins, antigenic peptides and anti-38650, 28472, 5495, 65507, 81588 or 14354 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

    摘要翻译： 本发明提供分离的核酸分子，命名为38650,28472,5495,65507,81588或14354核酸分子，其编码新的腺苷脱氨酶，糖蛋白酶或七个跨膜受体家族成员。 本发明还提供反义核酸分子，含有38650,28472,5495,65507,81588或14354核酸分子的重组表达载体，已经引入表达载体的宿主细胞，以及非人类转基因动物，其中38650,28472， 5495,65507,81588或14354基因被引入或破坏。 本发明还进一步提供了分离的38650,28472,5495,65507,81588或14354蛋白，融合蛋白，抗原肽和抗-38650,28472,5495,65507,81588或14354抗体。 还提供了利用本发明组合物的诊断方法。

    81588 methods and compositions of human proteins and uses thereof
    3.
    发明申请
    81588 methods and compositions of human proteins and uses thereof 审中-公开
    81588人蛋白质的方法和组合物及其用途

    公开(公告)号：US20060040306A1

    公开(公告)日：2006-02-23

    申请号：US11206587

    申请日：2005-08-18

    申请人： Kevin Leiby ,  Rosana Kapeller-Libermann ,  Maria Glucksmann

    发明人： Kevin Leiby ,  Rosana Kapeller-Libermann ,  Maria Glucksmann

    IPC分类号： C12Q1/68 ,  C07H21/04 ,  C12P21/06 ,  C07K14/82 ,  C07K16/30

    CPC分类号： C12N9/6489 ,  C07K14/705 ,  C07K2319/00 ,  C12N9/78 ,  C12Y304/24057 ,  C12Y305/04004

    摘要： The invention provides isolated nucleic acids molecules, designated 38650, 28472, 5495, 65507, 81588 or 14354 nucleic acid molecules, which encode novel adenosine deaminase, glycoprotease, or seven transmembrane receptor family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 38650, 28472, 5495, 65507, 81588 or 14354 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 38650, 28472, 5495, 65507, 81588 or 14354 gene has been introduced or disrupted. The invention still further provides isolated 38650, 28472, 5495, 65507, 81588 or 14354 proteins, fusion proteins, antigenic peptides and anti-38650, 28472, 5495, 65507, 81588 or 14354 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

    摘要翻译： 本发明提供分离的核酸分子，命名为38650,28472,5495,65507,81588或14354核酸分子，其编码新的腺苷脱氨酶，糖蛋白酶或七个跨膜受体家族成员。 本发明还提供反义核酸分子，含有38650,28472,5495,65507,81588或14354核酸分子的重组表达载体，已经引入表达载体的宿主细胞，以及非人类转基因动物，其中38650,28472， 5495,65507,81588或14354基因被引入或破坏。 本发明还进一步提供分离的38650,28472,5495,65507,81588或14354蛋白，融合蛋白，抗原肽和抗-38650,28472,5495,65507,81588或14354抗体。 还提供了利用本发明组合物的诊断方法。